Drug Trial Radar · NCT00151749
WelChol® and Insulin in Treating Patients With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Jan 18, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
260
Actual
Start
Jun 2004
Primary completion
Dec 2005
Study completion Dec 2005
Sponsor
- Lead sponsor
- Daiichi SankyoDaiichi Sankyo (DSNKY)
- Sponsor type
- Industry
- First posted
- Sep 9, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to see how safe and effective and tolerable the use of WelChol® is for type 2 diabetes when added to insulin alone or in combination with other anti-diabetic drugs
Conditions
- Type 2 Diabetes
Interventions
Colesevelam hydrochlorideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- - To assess the additional lowering of HbA1c achieved by
- addition of WelChol® to current antidiabetic therapy
Locations
47 sites in 3 countries. Site status is shown where the registry gives one.
Site not named
Tuscumbia, Alabama
Site not named
Sierra Vista, Arizona
Site not named
Jonesboro, Arkansas
Site not named
Searcy, Arkansas
Site not named
Carmichael, California
Site not named
Concord, California
Site not named
Fullerton, California
Site not named
La Jolla, California
Site not named
San Diego, California
Site not named
West Hills, California
Site not named
Washington D.C., District of Columbia
Site not named
Largo, Florida
Site not named
Miami, Florida
Site not named
New Port Richey, Florida
Site not named
West Palm Beach, Florida
Site not named
Chicago, Illinois
Site not named
Indianapolis, Indiana
Site not named
Lexington, Kentucky
Site not named
Louisville, Kentucky
Site not named
New Orleans, Louisiana
Site not named
Boston, Massachusetts
Site not named
Troy, Michigan
Site not named
Edina, Minnesota
Site not named
Chesterfield, Missouri
Site not named
Kansas City, Missouri
Site not named
St Louis, Missouri
Site not named
Bozeman, Montana
Site not named
Butte, Montana
Site not named
Englewood, New Jersey
Site not named
Charlotte, North Carolina
Site not named
Hickory, North Carolina
Site not named
Raleigh, North Carolina
Site not named
Statesville, North Carolina
Site not named
Winston-Salem, North Carolina
Site not named
Cincinnati, Ohio
Site not named
Marion, Ohio
Site not named
Portland, Oregon
Site not named
Beaver, Pennsylvania
Site not named
Charleston, South Carolina
Site not named
Bristol, Tennessee
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.